Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Malignant Pleural Mesotheliomas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +86 13076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Sacituzumab Govitecan in People With Mesothelioma

Mesothelioma · Mesotheliomas Pleural · Mesothelioma; Pleura

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Advanced Cancer · Advanced Solid Tumor · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Aurora, United States · Lake Mary, United States

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Pleural Mesotheliomas

Abroad (travel likely)RecruitingPHASE2

Besançon, France · Brest, France

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Mesothelioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Durham, United States · Houston, United States